• Dapps:16.23K
  • Blockchains:78
  • Active users:66.47M
  • 30d volume:$303.26B
  • 30d transactions:$879.24M

TREAT Release: Role in Shiba Inu Ecosystem and Spread of Misinformation

user avatar

by Giorgi Kostiuk

a year ago


The Shiba Inu ecosystem has announced the release of its new governance token TREAT. Alongside the official announcement, there have been issues with misinformation circulating within the community.

Official Announcement of TREAT

The Shiba Inu ecosystem officially confirmed that the TREAT token is set to be released in January 2025. This followed a delay initially attributed to fundraising efforts, such as the $12 million venture capital round for the Layer-3 blockchain.

Misinformation and Its Consequences

Despite the official confirmation, misinformation spread within the community. A user known as CryptoMumms claimed that TREAT was launched in January 2023, causing confusion. Shiba Inu's leader, known as Shytoshi Kusama, publicly refuted these claims on social media.

Treat did not stealth launch years ago. This simply isn't true.Shytoshi Kusama

TREAT's Role in the Shiba Inu Ecosystem

The TREAT token will be a key component in achieving full decentralization within Shiba Inu. It will be involved in the WOOF Wars: Farming 2.0 system and enable voting participation for holders. TREAT will also be integrated into SHIB Pay, an on-chain payment system advancing crypto-commerce.

Shiba Inu's official announcement regarding TREAT has clarified community concerns over miscommunication. The token is expected to play a significant role in the ecosystem's future, supporting decentralization and new use cases.

0

Rewards

chest
chest
chest
chest

More rewards

Discover enhanced rewards on our social media.

chest

Other news

Converge Bio's AI Platform Aims to Transform Drug Development

chest

Converge Bio is leveraging its newly acquired $25 million funding to enhance its AI platform, which focuses on drastically reducing the time and costs associated with drug development.

user avatarKenji Takahashi

Converge Bio Secures $25 Million Series A Funding to Transform Drug Discovery

chest

Converge Bio, a startup based in Boston and Tel Aviv, has raised $25 million in Series A funding to enhance AI-driven drug discovery.

user avatarMaria Fernandez

Buterin Continues Charity Donations from Token Sales

chest

Vitalik Buterin continues his practice of selling unsolicited tokens and donating the proceeds to charity, emphasizing ethical considerations in cryptocurrency promotions.

user avatarRajesh Kumar

Vitalik Buterin Sells Unsolicited Tokens for 94 ETH

chest

Ethereum cofounder Vitalik Buterin has sold unsolicited tokens from his wallet, converting them into 94 ETH.

user avatarGustavo Mendoza

Grayscale Segments Crypto Market into Five Vertical Categories

chest

Grayscale has categorized its altcoin candidates into five verticals, reflecting a structured approach to the crypto market.

user avatarMiguel Rodriguez

Decline in FLOW Price Amid Controversial Asset Recovery

chest

The price of FLOW has seen a significant decline following the Flow project's controversial asset recovery actions.

user avatarLuis Flores

Important disclaimer: The information presented on the Dapp.Expert portal is intended solely for informational purposes and does not constitute an investment recommendation or a guide to action in the field of cryptocurrencies. The Dapp.Expert team is not responsible for any potential losses or missed profits associated with the use of materials published on the site. Before making investment decisions in cryptocurrencies, we recommend consulting a qualified financial advisor.